✦ LIBER ✦

The SIRIUS-DIRECT trial: A multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesions

✍ Scribed by Jeffrey W. Moses; Giora Weisz; Gregory Mishkel; Ronald Caputo; Charles O'Shaughnessey; S. Chiu Wong; Tim A. Fischell; Michael Mooney; David O. Williams; Jeffrey J. Popma; Peter Fitzgerald; Sidney Smith; Richard E. Kuntz; Michael Collins; Sidney A. Cohen; Martin B. Leon

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 109 KB
Volume: 70
Category: Article
ISSN: 1522-1946
DOI: 10.1002/ccd.21162

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sirolimus PK trial: A pharmacokinetic st

Sirolimus PK trial: A pharmacokinetic study of the sirolimus-eluting Bx Velocity stent in patients with de novo coronary lesions

✍ George W. Vetrovec; David Rizik; Clark Williard; David Snead; Vladimir Piotrovsk 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

ISR II study: A long-term evaluation of

ISR II study: A long-term evaluation of sirolimus-eluting stent in the treatment of patients with in-stent restenotic native coronary artery lesions

✍ Philippe Commeau; Paul T. Barragan; Pierre O. Roquebert; Jean B. Siméoni 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 1 views

The aim of this pilot study was to determine the safety and long-term efficacy of treating intrastent restenosis (ISR) with the slow-release sirolimus-eluting stent Bx Velocity (Cypher stent) without intravascular ultrasound (IVUS) guidance. Of patients who received a bare metal stent implantation a

A randomized comparison of sirolimus-elu

A randomized comparison of sirolimus-eluting versus bare metal stents in the treatment of diabetic patients with native coronary artery lesions: The DECODE study

✍ Charles Chan; Robaayah Zambahari; Upendra Kaul; CP Lau; Hall Whitworth; Sidney C 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB 👁 1 views

Four-year clinical follow-up of the XIEN

Four-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: The SPIRIT II trial

✍ Scot Garg; Patrick W. Serruys; Karine Miquel-Hebert; on behalf of the SPIRIT II 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB 👁 2 views

## Abstract This report describes the 4‐year clinical outcomes of the SPIRIT II study, which randomized 300 patients to treatment with the XIENCE V everolimus‐eluting stent (EES), or the TAXUS paclitaxel‐eluting stent. At 4‐year clinical follow‐up, which was available in 256 (85.3%) patients, treat

Five-year long-term clinical follow-up o

Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: The SPIRIT FIRST trial

✍ Marcus Wiemer; Patrick W. Serruys; Karine Miquel-Hebert; Franz-Josef Neumann; Ja 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 2 views

Two-year follow-up of the genous™ endoth

Two-year follow-up of the genous™ endothelial progenitor cell capturing stent versus the taxus liberté stent in patients with De Novo coronary artery lesions with a high-risk of restenosis : A randomized, single-center, pilot study

✍ Marcel A.M. Beijk; Margo Klomp; Nan van Geloven; Karel T. Koch; José P.S. Henriq 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 1 views